These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9836457)
1. Synthesis of substituted 2-ethoxycarbonyl- and 2-carboxyquinoxalin-3-ones for evaluation of antimicrobial and anticancer activity. Sanna P; Carta A; Loriga M; Zanetti S; Sechi L Farmaco; 1998 Jul; 53(7):455-61. PubMed ID: 9836457 [TBL] [Abstract][Full Text] [Related]
2. Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity. Vitale G; Corona P; Loriga M; Paglietti G Farmaco; 1998; 53(8-9):594-601. PubMed ID: 10081824 [TBL] [Abstract][Full Text] [Related]
3. Quinoxaline chemistry. Part 13: 3-Carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activity. Corona P; Vitale G; Loriga M; Paglietti G Farmaco; 2000 Feb; 55(2):77-86. PubMed ID: 10782376 [TBL] [Abstract][Full Text] [Related]
5. Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity. Alleca S; Corona P; Loriga M; Paglietti G; Loddo R; Mascia V; Busonera B; La Colla P Farmaco; 2003 Sep; 58(9):639-50. PubMed ID: 13679156 [TBL] [Abstract][Full Text] [Related]
6. Quinoxalin-2-ones. Part 5. Synthesis and antimicrobial evaluation of 3-alkyl-, 3-halomethyl- and 3-carboxyethylquinoxaline-2-ones variously substituted on the benzo-moiety. Carta A; Loriga M; Zanetti S; Sechi LA Farmaco; 2003 Dec; 58(12):1251-5. PubMed ID: 14630235 [TBL] [Abstract][Full Text] [Related]
7. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity. Loriga M; Moro P; Sanna P; Paglietti G; Zanetti S Farmaco; 1997; 52(8-9):531-7. PubMed ID: 9507661 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation for biological activity of 3-alkyl and 3-halogenoalkyl-quinoxalin-2-ones variously substituted. Part 4. Carta A; Sanna P; Loriga M; Setzu MG; La CP; Loddo R Farmaco; 2002 Jan; 57(1):19-25. PubMed ID: 11902641 [TBL] [Abstract][Full Text] [Related]
9. DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF 2,3-DISUBSTITUTED AND FUSED QUINOXALINES AS POTENTIAL ANTICANCER AND ANTIMICROBIAL AGENTS. Abbas HS; Al-Marhabi ARM; Ammar YA Acta Pol Pharm; 2017 Mar; 74(2):445-458. PubMed ID: 29624250 [TBL] [Abstract][Full Text] [Related]
10. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones. Ramalingam P; Ganapaty S; Rao ChB Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890 [TBL] [Abstract][Full Text] [Related]
11. Quinoxaline chemistry. Part 5. 2-(R)-benzylaminoquinoxalines as nonclassical antifolate agents. Synthesis and evaluation of in vitro anticancer activity. Loriga M; Fiore M; Sanna P; Paglietti G Farmaco; 1996; 51(8-9):559-68. PubMed ID: 8930109 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of some halogen-containing 1,2,4-triazolo-1,3,4-thiadiazines and their antibacterial and anticancer screening studies--part I. Holla BS; Sarojini BK; Rao BS; Akberali PM; Kumari NS; Shetty V Farmaco; 2001 Aug; 56(8):565-70. PubMed ID: 11601641 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of certain substituted quinoxalines as antimicrobial agents (Part II). Badran MM; Abouzid KA; Hussein MH Arch Pharm Res; 2003 Feb; 26(2):107-13. PubMed ID: 12643584 [TBL] [Abstract][Full Text] [Related]
14. Chemistry, biological properties and SAR analysis of quinoxalinones. Carta A; Piras S; Loriga G; Paglietti G Mini Rev Med Chem; 2006 Nov; 6(11):1179-200. PubMed ID: 17100630 [TBL] [Abstract][Full Text] [Related]
15. Quinoxaline chemistry. Part 14. 4-(2-Quinoxalylamino)-phenylacetates and 4-(2-quinoxalylamino)-phenylacetyl-L-glutamates as analogues--homologues of classical antifolate agents. Synthesis and evaluation of in vitro anticancer activity. Piras S; Loriga M; Paglietti G Farmaco; 2002 Jan; 57(1):1-8. PubMed ID: 11902640 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of antimicrobial 2,9,10-trisubstituted-6-oxo-7,12-dihydro-chromeno[3,4-b]quinoxalines. Kotharkar SA; Shinde DB Bioorg Med Chem Lett; 2006 Dec; 16(24):6181-4. PubMed ID: 17027265 [TBL] [Abstract][Full Text] [Related]
17. Bifunctional ethyl 2-amino-4-methylthiazole-5-carboxylate derivatives: synthesis and in vitro biological evaluation as antimicrobial and anticancer agents. Rostom SA; Faidallah HM; Radwan MF; Badr MH Eur J Med Chem; 2014 Apr; 76():170-81. PubMed ID: 24583356 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities. El-Hawash SA; Habib NS; Kassem MA Arch Pharm (Weinheim); 2006 Oct; 339(10):564-71. PubMed ID: 17009301 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and initial biological evaluation of substituted 1-phenylamino-2-thio-4,5-dimethyl-1H-imidazole derivatives. Yurttaş L; Duran M; Demirayak Ş; Gençer HK; Tunalı Y Bioorg Med Chem Lett; 2013 Dec; 23(24):6764-8. PubMed ID: 24176398 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione. El-Hawash SA; Wahab AE Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]